Free Access
Med Sci (Paris)
Volume 23, Number 11, Novembre 2007
Page(s) 968 - 974
Section M/S revues
Published online 15 November 2007
  1. Stiller CA. Epidemiology and genetics of childhood cancer. Oncogene 2004; 23 : 6429–44. [Google Scholar]
  2. Krajinovic M, Labuda D, Richer C, et al. Susceptibility to childhood acute lymphoblastic leukemia : influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms. Blood 1999; 93 : 1496–501. [Google Scholar]
  3. Sinnett D, Krajinovic M, Labuda D. Genetic susceptibility to childhood acute lymphoblastic leukemia. Leuk Lymphoma 2000; 38 : 447–62. [Google Scholar]
  4. Meyer UA, Zanger UM. Molecular mechanisms of genetic polymorphisms of drug metabolism. Annu Rev Pharmacol Toxicol 1997; 37 : 269–96. [Google Scholar]
  5. Vatsis KP, Weber WW, Bell DA, et al. Nomenclature for N-acetyltransferases. Pharmacogenetics 1995; 5 : 1–17. [Google Scholar]
  6. d’Errico A, Taioli E, Chen X, Vineis P. Genetic metabolic polymorphisms and the risk of cancer : a review of the literature. Biomarkers 1996; 1 : 149–73. [Google Scholar]
  7. Krajinovic M, Richer C, Sinnett H, et al. Genetic polymorphisms of N-acetyltransferases 1 and 2 and gene-gene interaction in the susceptibility to childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev 2000; 9 : 557–62. [Google Scholar]
  8. Daly AK, Fairbrother KS, Smart J. Recent advances in understanding the molecular basis of polymorphisms in genes encoding cytochrome P450 enzymes. Toxicol Lett 1998; 102-103 : 143–7. [Google Scholar]
  9. Kato S, Bowman ED, Harrington AM, et al. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo. J Natl Cancer Inst 1995; 87 : 902–7. [Google Scholar]
  10. Shields PG. Pharmacogenetics : detecting sensitive populations. Environ Health Perspect 1994; 102 (suppl 11) : 81–7. [Google Scholar]
  11. Krajinovic M, Sinnett H, Richer C, et al. Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Int J Cancer 2002; 97 : 230–6. [Google Scholar]
  12. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family : regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995; 30 : 445–600. [Google Scholar]
  13. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997; 6 : 733–43. [Google Scholar]
  14. Cossar D, Bell J, Strange R, et al. The alpha and pi isoenzymes of glutathione S-transferase in human fetal lung : in utero ontogeny compared with differentiation in lung organ culture. Biochim Biophys Acta 1990; 1037 : 221–6. [Google Scholar]
  15. Harries LW, Stubbins MJ, Forman D, et al. Identification of genetic polymorphisms at the glutathione S- transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 1997; 18 : 641–4. [Google Scholar]
  16. Hu X, Xia H, Srivastava SK, et al. Activity of four allelic forms of glutathione S-transferase hGSTP1-1 for diol epoxides of polycyclic aromatic hydrocarbons. Biochem Biophys Res Commun 1997; 238 : 397–402. [Google Scholar]
  17. Krajinovic M, Labuda D, Sinnett D. Glutathione S-transferase P1 genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukaemia. Pharmacogenetics 2002; 12 : 655–8. [Google Scholar]
  18. Watson MA, Stewart RK, Smith GB, et al. Human glutathione S-transferase P1 polymorphisms : relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 1998; 19 : 275–80. [Google Scholar]
  19. Sundberg K, Johansson AS, Stenberg G, et al. Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis 1998; 19 : 433–6. [Google Scholar]
  20. Hiley C, Bell J, Hume R, Strange R. Differential expression of alpha and pi isoenzymes of glutathione S-transferase in developing human kidney. Biochim Biophys Acta 1989; 990 : 321–4. [Google Scholar]
  21. Kettle AJ, Winterbourn CC. Oxidation of hydroquinone by myeloperoxidase. Mechanism of stimulation by benzoquinone. J Biol Chem 1992; 267 : 8319–24. [Google Scholar]
  22. Piedrafita FJ, Molander RB, Vansant G, et al. An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J Biol Chem 1996; 271 : 14412–20. [Google Scholar]
  23. Reynolds WF, Chang E, Douer D, et al. An allelic association implicates myeloperoxidase in the etiology of acute promyelocytic leukemia. Blood 1997; 90 : 2730–7. [Google Scholar]
  24. Cascorbi I, Henning S, Brockmoller J, et al. Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant--463A of the myeloperoxidase gene. Cancer Res 2000; 60 : 644–9. [Google Scholar]
  25. Gaedigk A, Tyndale RF, Jurima-Romet M, et al. NAD(P)H : quinone oxidoreductase : polymorphisms and allele frequencies in Caucasian, Chinese and Canadian Native Indian and Inuit populations. Pharmacogenetics 1998; 8 : 305–13. [Google Scholar]
  26. Larson RA, Wang Y, Banerjee M, et al. Prevalence of the inactivating 609C-T polymorphism in the NAD(P)H : quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia. Blood 1999; 94 : 803–7. [Google Scholar]
  27. Wiemels JL, Pagnamenta A, Taylor GM, et al. A lack of a functional NAD(P)H : quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. United Kingdom Childhood Cancer Study Investigators. Cancer Res 1999; 59 : 4095–9. [Google Scholar]
  28. Fairbrother KS, Grove J, de Waziers I, et al. Detection and characterization of novel polymorphisms in the CYP2E1 gene. Pharmacogenetics 1998; 8 : 543–52. [Google Scholar]
  29. Smith MT. Benzene, NQO1, and genetic susceptibility to cancer. Proc Natl Acad Sci USA 1999; 96 : 7624–6. [Google Scholar]
  30. Infante-Rivard C, Labuda D, Krajinovic M, Sinnett D. Risk of childhood leukemia associated with exposure to pesticides and with gene polymorphisms. Epidemiology 1999; 10 : 481–7. [Google Scholar]
  31. Clavel J, Bellec S, Rebouissou S, et al. Childhood leukaemia, polymorphisms of metabolism enzyme genes, and interactions with maternal tobacco, coffee and alcohol consumption during pregnancy. Eur J Cancer Prev 2005; 14 : 531–40. [Google Scholar]
  32. Infante-Rivard C, Sinnett D. Preconceptional paternal exposure to pesticides and increased risk of childhood leukaemia. Lancet 1999; 354 : 1819. [Google Scholar]
  33. Infante-Rivard C, Krajinovic M, Labuda D, Sinnett D. Parental smoking, CYP1A1 genetic polymorphisms and childhood leukemia (Quebec, Canada). Cancer Causes Control 2000; 11 : 547–53. [Google Scholar]
  34. Joseph T, Kusumakumary P, Chacko P, et al. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children. Pediatr Blood Cancer 2004; 43 : 560–7. [Google Scholar]
  35. Infante-Rivard C, Krajinovic M, Labuda D, Sinnett D. Childhood acute lymphoblastic leukemia associated with parental alcohol consumption and carcinogen-metabolizing genetic polymorphisms. Epidemiology 2002; 13 : 277–81. [Google Scholar]
  36. Infante-Rivard C, Amre D, Sinnett D. GSTT1 and CYP2E1 polymorphisms and trihalomethanes in drinking water : effect on childhood leukemia. Environ Health Perspect 2002; 110 : 591–3. [Google Scholar]
  37. Aydin-Sayitoglu M, Hatirnaz O, Erensoy N, Ozbek U. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias. Am J Hematol 2006; 81 : 162–70. [Google Scholar]
  38. Pakakasama S, Mukda E, Sasanakul W, et al. Polymorphisms of drug-metabolizing enzymes and risk of childhood acute lymphoblastic leukemia. Am J Hematol 2005; 79 : 202–5. [Google Scholar]
  39. Wang J, Zhang L, Feng J, et al. Genetic polymorphisms analysis of glutathion S-transferase M1 and T1 in children with acute lymphoblastic leukemia. J Huazhong Univ Sci Technolog Med Sci 2004; 24 : 243–244. [Google Scholar]
  40. Canalle R, Burim RV, Tone LG, Takahashi CS. Genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia. Environ Mol Mutagen 2004; 43 : 100–9. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.